Skip to main content
. Author manuscript; available in PMC: 2009 Jan 5.
Published in final edited form as: Virology. 2007 Oct 24;370(1):130–141. doi: 10.1016/j.virol.2007.08.022

Fig. 4.

Fig. 4

Cross-clade CTL responses in monkeys vaccinated with the HIV-1 envelope peptide-cocktail. Higher CTL responses, specific to HIV-1 envelope sequences corresponding to 8 different clade HIV-1 isolates, in addition to HIV-1IIIB, were observed in the vaccinated monkey compared to that in a control monkey and the responses in the vaccinated monkey increasedsubstantially after SHIVKU2-challenge (post-SHIV) compared to levels prior to challenge (pre-SHIV). The CTL assay was performed as described in Fig. 2C, and the results are shown for the 25:1 effecter to target ratio for a representative monkey from the control and vaccinated groups.